This article reports on results of a clinical trial evaluating two routes of misoprostol administration following mifepristone for early medical abortion. For gestations through 56 days since last menstrual period 400mcg of oral misoprostol performed better than a 400mcg sublingual dose when following 200mg mifepristone although not significantly so.

Access the abstract.

Jun. 2009
Staff Publication
Medical Abortion
Dabash, Rasha, Winikoff, Beverly, Akın, A., Dabash, R., Dilbaz, B, Aktun, H., Dursun, P., Kıran, S., Aksan, G., Dogan, B., Winikoff, B.